Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations

Podobne zapisy

• Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
  od: Masuda, Tomomi, i wsp.
  Wydane: (2020)
• Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
  od: Russano, Marco, i wsp.
  Wydane: (2020)
• Cabozantinib and apixaban: an hitherto unreported interaction
  od: Santini, Daniele, i wsp.
  Wydane: (2019)
• The Effectiveness of Afatinib in a Patient with Advanced Lung Adenocarcinoma Harboring Rare G719X and S768I Mutations
  od: Watanabe, Masahiro, i wsp.
  Wydane: (2017)
• Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
  od: Tonini, Giuseppe, i wsp.
  Wydane: (2013)